Sign In
Buy ATNM
$0.84
-0.0001 (-0.0119%)
At Close: Jul 31, 2026
- ATNM-400 demonstrates robust efficacy in prostate cancer tumor models with acquired resistance to Pluvicto ® and enzalutamide, follow-up continues - ATNM-400 significantly improve
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting
11:30am, Monday, 23'rd Jun 2025
- ATNM-400 shows; superior prostate cancer cell killing compared to androgen receptor inhibitor Xtandi® (enzalutamide), the ability to overcome Xtandi resistance, and activity in combination - AT
Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm
11:36am, Tuesday, 10'th Jun 2025
NEW YORK , June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) br
Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025 - Contact Levi & Korsinsky
12:35pm, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
Levi & Korsinsky Urges Actinium (ATNM) Shareholders to Act Before Lead Plaintiff Deadline May 27, 2025
11:00am, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Rosen Law Firm: WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE America
Securities Class Action Lawsuit Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - Levi & Korsinsky Represents Shareholders
04:30pm, Monday, 26'th May 2025
NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed a
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline May 27, 2025
02:00pm, Monday, 26'th May 2025
NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025 - Contact Levi & Korsinsky
11:30am, Monday, 26'th May 2025
NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK , May 26, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM). Such inve
NEW YORK , May 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between Octobe
Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM) - Join by May 27, 2025 - Contact Levi & Korsinsky
07:30am, Monday, 26'th May 2025
NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actiniu
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025
06:17pm, Sunday, 25'th May 2025
NEW YORK, NY / ACCESS Newswire / May 25, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu
